Production (Stage)
Amicus Therapeutics, Inc.
FOLD
$6.22
-$0.04-0.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -247.13% | 319.04% | 57.13% | 67.58% | -43.07% |
| Total Depreciation and Amortization | -10.00% | -5.94% | -0.55% | 1.30% | -1.28% |
| Total Amortization of Deferred Charges | 1.51% | 4.01% | 2.50% | 5.46% | -0.93% |
| Total Other Non-Cash Items | -6.48% | -10.19% | 1.78% | -35.99% | 13.19% |
| Change in Net Operating Assets | 113.74% | 0.54% | -496.48% | 149.70% | -3,306.61% |
| Cash from Operations | 298.11% | 82.95% | -201.23% | 176.41% | -958.73% |
| Capital Expenditure | 26.39% | 19.10% | 67.58% | 39.37% | -4.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.40% | -158.06% | 265.85% | -323.35% | 142.06% |
| Cash from Investing | -61.15% | -159.50% | 255.94% | -391.59% | 131.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 65.12% | -279.17% | 166.67% | 14.29% | 99.99% |
| Issuance of Common Stock | -94.66% | -90.61% | 2,328.51% | -75.01% | -89.29% |
| Repurchase of Common Stock | -1,323.91% | 70.34% | -65.80% | 89.93% | -968.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,166.55% | -93.97% | 2,222.52% | 93.56% | -262.11% |
| Foreign Exchange rate Adjustments | 55.10% | 161.79% | -1,610.20% | 83.81% | 53.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.09% | -182.18% | 5,697.94% | 98.83% | -130.21% |